Business Description
![Algorae Pharmaceuticals Ltd Algorae Pharmaceuticals Ltd logo](https://static.gurufocus.com/logos/0C00000LVJ.png?14)
Algorae Pharmaceuticals Ltd
ISIN : AU0000296022
Compare
Compare
Traded in other countries / regions
1AI.AustraliaLHI0.GermanyLVCLF.USA IPO Date
2006-01-24Description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26.3 | |||||
3-Year EPS without NRI Growth Rate | -26 | |||||
3-Year FCF Growth Rate | 41.5 | |||||
3-Year Book Growth Rate | -26.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.47 | |||||
14-Day RSI | 95.6 | |||||
6-1 Month Momentum % | -8 | |||||
12-1 Month Momentum % | -25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 26.84 | |||||
Quick Ratio | 26.84 | |||||
Cash Ratio | 25.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.1 | |||||
Shareholder Yield % | -2.81 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -66.8 | |||||
ROA % | -60.93 | |||||
ROIC % | -5898.31 | |||||
ROC (Joel Greenblatt) % | -18810.81 | |||||
ROCE % | -66.3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.5 | |||||
EV-to-EBIT | -6.44 | |||||
EV-to-EBITDA | -6.44 | |||||
EV-to-FCF | -8.11 | |||||
Earnings Yield (Greenblatt) % | -15.53 | |||||
FCF Yield % | -9.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LVCLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Algorae Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.001 | ||
Beta | -0.82 | ||
Volatility % | 101.56 | ||
14-Day RSI | 95.6 | ||
14-Day ATR ($) | 0.000013 | ||
20-Day SMA ($) | 0.0069 | ||
12-1 Month Momentum % | -25 | ||
52-Week Range ($) | 0.0037 - 0.0127 | ||
Shares Outstanding (Mil) | 1,687.39 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Algorae Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Algorae Pharmaceuticals Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Algorae Pharmaceuticals Ltd Frequently Asked Questions
What is Algorae Pharmaceuticals Ltd(LVCLF)'s stock price today?
The current price of LVCLF is $0.01. The 52 week high of LVCLF is $0.01 and 52 week low is $0.00.
When is next earnings date of Algorae Pharmaceuticals Ltd(LVCLF)?
The next earnings date of Algorae Pharmaceuticals Ltd(LVCLF) is .
Does Algorae Pharmaceuticals Ltd(LVCLF) pay dividends? If so, how much?
Algorae Pharmaceuticals Ltd(LVCLF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |